Viewing Study NCT00087269


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2026-04-06 @ 7:10 AM
Study NCT ID: NCT00087269
Status: TERMINATED
Last Update Posted: 2013-06-06
First Post: 2004-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module